Showing results (101-110 of 108) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Blood|June 15, 1992
T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remissionJ W Young, E B Papadopoulos, I Cunningham, et al.Blood|October 15, 1993
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell doseW R Drobyski, C A Keever, M S Roth, et al.British Journal of Haematology|July 1, 1996
Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adultsD Margolis, B Camitta, D Pietryga, et al.Bone Marrow Transplantation|July 3, 2003
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trialL J Burns, D J Weisdorf, T E DeFor, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletionC A Keever-Taylor, C Bredeson, F R Loberiza, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I studyG L Phillips, B Meisenberg, D E Reece, et al.Bone Marrow Transplantation|February 10, 2004
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphomaG L Phillips, B R Meisenberg, D E Reece, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblingsR Szydlo, J M Goldman, J P Klein, et al.Pageof 11